Trends in alternative medicine use in the United States 1990-1997: results of a follow-up national survey
The analyses were conducted on the above cohorts: (1) SGLT2i and (2) GLP-1 RA with each analysis propensity score matched (PSM) for age, sex, BMI, presence of heart failure (ICD-10-CM-I50), hypertension (ICD-10-CM-I10), ischaemic heart disease (IHD) (ICD-10-CM-I2025), chronic kidney disease (CKD) (ICD-10-CM-N18) and HbA 1c value so as to balance the analysis (1:1 matching) being undertaken
Semaglutide is an FDA-approved medication designed to support weight loss by reducing appetite and enhancing feelings of fullness
It is designed to support fat metabolism, cellular energy, and overall metabolic health through convenient and precise dosing
These agencies assessed the clinical trial data, ensuring the drugs safety, efficacy, and quality
Your prescribing physician needs to evaluate whether switching from Tirzepatide to Retatrutide is right for your medical history